133 related articles for article (PubMed ID: 29052741)
1. [Regional differences of ADHD diagnosis rates in health insurance data from 2005 to 2015 : Methodological considerations and results].
Grobe TG
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Dec; 60(12):1336-1345. PubMed ID: 29052741
[TBL] [Abstract][Full Text] [Related]
2. The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007.
Schubert I; Köster I; Lehmkuhl G
Dtsch Arztebl Int; 2010 Sep; 107(36):615-21. PubMed ID: 20948775
[TBL] [Abstract][Full Text] [Related]
3. Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany.
Lindemann C; Langner I; Kraut AA; Banaschewski T; Schad-Hansjosten T; Petermann U; Petermann F; Schreyer-Mehlhop I; Garbe E; Mikolajczyk RT
J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):307-14. PubMed ID: 22856384
[TBL] [Abstract][Full Text] [Related]
4. ADHD in Germany: Trends in Diagnosis and Pharmacotherapy.
Bachmann CJ; Philipsen A; Hoffmann F
Dtsch Arztebl Int; 2017 Mar; 114(9):141-148. PubMed ID: 28351466
[TBL] [Abstract][Full Text] [Related]
5. Potential Explanations for Increasing Methylphenidate Use in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder in Germany From 2004 to 2013.
Langner I; Haug U; Scholle O; Lindemann C; Schröder C; Riedel O
J Clin Psychopharmacol; 2019; 39(1):39-45. PubMed ID: 30489381
[TBL] [Abstract][Full Text] [Related]
6. [Methylphenidate prescriptions in the city of Cologne: overrepresentation of privately insured patients. Results of an analysis based on prescription data].
Bessou H; Zeeb H; Puteanus U
Gesundheitswesen; 2007 May; 69(5):292-6. PubMed ID: 17582546
[TBL] [Abstract][Full Text] [Related]
7. [Has the prevalence of parent-reported diagnosis of attention deficit hyperactivity disorder (ADHD) in Germany increased between 2003-2006 and 2009-2012? Results of the KiGGS-study: first follow-up (KiGGS Wave 1)].
Schlack R; Mauz E; Hebebrand J; Hölling H;
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jul; 57(7):820-9. PubMed ID: 24950831
[TBL] [Abstract][Full Text] [Related]
8. Overlapping Prescriptions of Stimulants for Children and Adolescents With Attention-Deficit Hyperactivity Disorder.
Chen CY; Yeh HH; Fang SY; Wu EC; Chang IS; Lin KM
Psychiatr Serv; 2012 Oct; 63(10):1011-8. PubMed ID: 22911441
[TBL] [Abstract][Full Text] [Related]
9. Injury prevention by medication among children with attention-deficit/hyperactivity disorder: a case-only study.
Mikolajczyk R; Horn J; Schmedt N; Langner I; Lindemann C; Garbe E
JAMA Pediatr; 2015 Apr; 169(4):391-5. PubMed ID: 25686215
[TBL] [Abstract][Full Text] [Related]
10. [Hyperkinetic disorders in children and adolescents in Germany: administrative prevalence and regional differences regarding the frequency of diagnosis assignment].
Roick C; Waltersbacher A
Psychiatr Prax; 2015 Jan; 42(1):21-9. PubMed ID: 24062156
[TBL] [Abstract][Full Text] [Related]
11. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
[TBL] [Abstract][Full Text] [Related]
12. [Age- and Gender-specific Costs as Well as Drug Therapies of ADHD Patients].
Klora M; Zeidler J; Lublow D; Linder R; Verheyen F; von der Schulenburg JM
Gesundheitswesen; 2016 Jul; 78(7):e23-9. PubMed ID: 26695543
[TBL] [Abstract][Full Text] [Related]
13. The Israel Survey of Mental Health among Adolescents: prevalence of attention-deficit/hyperactivity disorder, comorbidity, methylphenidate use, and help-seeking patterns.
Farbstein I; Mansbach-Kleinfeld I; Auerbach JG; Ponizovsky AM; Apter A
Isr Med Assoc J; 2014 Sep; 16(9):568-73. PubMed ID: 25351015
[TBL] [Abstract][Full Text] [Related]
14. Attention-deficit hyperactivity disorder in Manitoba children: medical diagnosis and psychostimulant treatment rates.
Brownell MD; Yogendran MS
Can J Psychiatry; 2001 Apr; 46(3):264-72. PubMed ID: 11320681
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of medically treated children with ADHD and type 1 diabetes in Germany - Analysis of two representative databases.
Kapellen TM; Reimann R; Kiess W; Kostev K
J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1293-1297. PubMed ID: 27754966
[TBL] [Abstract][Full Text] [Related]
16. [The use of methylphenidate in children: analysis of prescription usage based in routine data of the statutory health insurance bodies concerning drug prescriptions].
Schmidt-Troschke SO; Ostermann T; Melcher D; Schuster R; Erben CM; Matthiessen PF
Gesundheitswesen; 2004 Jun; 66(6):387-92. PubMed ID: 15206042
[TBL] [Abstract][Full Text] [Related]
17. Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany.
Greven P; Sikirica V; Chen YJ; Curtice TG; Makin C
Eur J Health Econ; 2017 Sep; 18(7):893-904. PubMed ID: 27817164
[TBL] [Abstract][Full Text] [Related]
18. [The prevalence of attention-deficit/hyperactivity disorder (ADHD) among children and adolescents in Germany. Initial results from the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)].
Schlack R; Hölling H; Kurth BM; Huss M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007; 50(5-6):827-35. PubMed ID: 17514469
[TBL] [Abstract][Full Text] [Related]
19. Who cares for patients with attention-deficit/hyperactivity disorder (ADHD)? Insights from Nordbaden (Germany) on administrative prevalence and physician involvement in health care provision.
Schlander M; Schwarz O; Trott GE; Viapiano M; Bonauer N
Eur Child Adolesc Psychiatry; 2007 Oct; 16(7):430-8. PubMed ID: 17468967
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of and change in the prescription of methylphenidate in Israel over a 2-year period.
Fogelman Y; Vinker S; Guy N; Kahan E
CNS Drugs; 2003; 17(12):915-9. PubMed ID: 12962530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
